Astonea Labs Private Limited
Glimepiride (0.5mg) + Metformin (500mg)
Glimtoss 0.5mg/500mg Tablet is a combination of two medicines used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes.
Tablet
Glimtoss 0.5mg/500mg Tablet belongs to a category of medicines known as anti-diabetic drugs. It is a combination of two medicines used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Glimtoss 0.5mg/500mg Tablet is to be taken with food.
It can cause hypoglycemia (low blood sugar level) when used with other antidiabetic medicines, alcohol or if you delay or miss a meal.
It is unsafe to consume alcohol with Glimtoss 0.5mg/500mg Tablet.
Glimtoss 0.5mg/500mg Tablet is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby.
Glimtoss 0.5mg/500mg Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Glimtoss 0.5mg/500mg Tablet is a combination of two antidiabetic medicines: Glimepiride and Metformin. Glimepiride is a sulfonylurea which works by increasing the amount of insulin released by the pancreas in order to lower the blood glucose. Metformin is a biguanide which works by lowering glucose production in the liver, delaying glucose absorption from intestines and increasing the body's sensitivity to insulin.
Monitor your blood sugar level regularly while you are taking this medicine. Inform your doctor about your diabetes treatment if you are due to have surgery under a general anesthetic. Tell your doctor immediately if you experience any deep or rapid breathing or if you have persistent nausea, vomiting and stomach pain as Glimtoss 0.5mg/500mg Tablet may cause a rare but serious condition called lactic acidosis which is an excess of lactic acid in the blood.
Store this medicine in the container or pack it came in, tightly closed. Follow the instructions on the label or package for further guidance on proper storage. Dispose of unused medication properly and ensure that it is inaccessible to pets, children, and others.
Yes, the use of Glimtoss 0.5mg/500mg Tablet can lead to lactic acidosis. It is a medical emergency that arises from an increase in lactic acid levels within the blood. This condition is commonly referred to as MALA (Metformin-associated lactic acidosis). This side effect is relatively rare but carries significant health risks for individuals with pre-existing kidney diseases, elderly patients, or those who frequently consume alcohol in large quantities. Symptoms may include muscle pain or weakness, dizziness, fatigue, feelings of coldness in the arms and legs, difficulty breathing, nausea, vomiting, stomach pain, or a slowed heart rate. If you experience these symptoms while taking Glimtoss 0.5mg/500mg Tablet, discontinue its use immediately and consult your doctor promptly.
Glimtoss 0.5mg/500mg Tablet is a combination of two medications: Glimepiride and Metformin. This medicine is used for the treatment of type 2 diabetes mellitus (DM). It improves blood glucose levels in adults when taken along with proper diet and regular exercise. Glimepiride lowers blood glucose levels by increasing insulin release from the pancreas. Metformin, on the other hand, reduces glucose production by the liver and improves insulin sensitivity. This combination is not used for the treatment of type 1 DM.
Like most medications, Glimtoss 0.5mg/500mg Tablet may cause side effects. These can include hypoglycemia (low blood sugar), alterations in taste, nausea, stomach pain, diarrhea, and headache. In some cases, it can also lead to serious but rare side effects such as lactic acidosis. Long-term use of this medication has been associated with a possible deficiency of vitamin B12.
Yes, long-term use of Glimtoss 0.5mg/500mg Tablet can lead to vitamin B12 deficiency. This is due to its impact on the stomach's ability to absorb vitamin B12 effectively. If left untreated, it can result in anemia and neurological issues like tingling and numbness in hands and feet, weakness, urinary problems, mental status changes, and difficulties with balance (ataxia). To mitigate these risks, consider consuming a source of Vitamin B12 through external supplements at least once annually.
Yes, the use of Glimtoss 0.5mg/500mg Tablet can lead to hypoglycemia (low blood sugar level). It is important to be aware of symptoms such as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and feelings of anxiety or shakiness. These effects are more likely when you miss meals, drink alcohol, over-exercise, or use other medications that can impact blood glucose levels simultaneously.
No, combining Glimtoss 0.5mg/500mg Tablet with alcohol is not recommended as it can significantly lower blood sugar levels and increase the risk of hypoglycemia. It also elevates the likelihood of lactic acidosis.